Global Cell Expansion Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Cell Expansion Market is presumed to reach the market size of nearly USD 32.55 Billion by 2032 from USD 24.15 Billion in 2023 with a CAGR of 3.37% under the study period 2024-2032.

Cell expansion increases cell number in a culture through cell proliferation or growth, typically for biomedical and biotechnological applications. It involves providing cells with the necessary nutrients, growth factors, and environmental conditions to stimulate their division and replication while maintaining their viability and functionality. It is essential for producing sufficient quantities of cells for various purposes, such as cell therapy, tissue engineering, drug screening, and research studies.

MARKET DYNAMICS

The cell expansion market is driven by factors such as the prevalence of chronic diseases, advancements in cell-based research, and the growing demand for regenerative medicine and personalized therapies. Chronic diseases, such as cancer & diabetes, require innovative treatment approaches, with cell expansion crucial in developing cell-based therapies. The surge in research activities focusing on stem cells and other cell types has led to significant technological advancements, improving the efficiency and scalability of producing therapeutic cells. Regenerative medicine aims to repair or replace damaged tissues & organs and relies heavily on cell expansion to provide sufficient functional cells. Additionally, increased funding and investment in biopharmaceutical research and development drive the market, enabling further innovation and application of cell-based therapies. However, scalability issues and regulatory hurdles may hinder the market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell Expansion. The growth and trends of Cell Expansion industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cell Expansion market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Consumables (Reagents, Media, & Serum, Other Consumables)
Culture Flasks and Accessories (Tissue Culture Flasks, Bioreactor Accessories, Other Culture Flasks and Accessories)
Instruments (Automated Cell Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Other Instruments)

By Cell Type

Mammalian (Human (Stem Cells (SCs), Adult SCs, Embryonic SCs, Induced Pluripotent SCs, Differentiated Cells), Animal)
Microbial
Others

By Application

Biopharmaceuticals
Tissue Culture & Engineering
Vaccine Production
Drug Development
Gene Therapy
Cancer Research
Stem Cell Research
Others

By End-use

Biopharmaceutical & Biotechnology Companies
Research Institutes
Cell Banks
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Expansion market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Expansion market include Thermo Fisher Scientific Inc., GE Healthcare, Corning Incorporated, Merck KGaA, Miltenyi Biotec, BD (Becton, Dickinson And Company), Terumo BCT Inc., Sartorius AG, Takara Bio Inc., Trinova Biochem GmbH, Upcyte Technologies GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11214682

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CELL EXPANSION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Cell Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL EXPANSION MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Consumables (Reagents, Media, & Serum, Other Consumables) Historic and Forecast Sales By Regions
5.4. Culture Flasks and Accessories (Tissue Culture Flasks, Bioreactor Accessories, Other Culture Flasks and Accessories) Historic and Forecast Sales By Regions
5.5. Instruments (Automated Cell Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Other Instruments) Historic and Forecast Sales By Regions

6. GLOBAL CELL EXPANSION MARKET ANALYSIS BY CELL TYPE

6.1. Overview By Cell Type
6.2. Historical and Forecast Data Analysis By Cell Type
6.3. Mammalian (Human (Stem Cells (SCs), Adult SCs, Embryonic SCs, Induced Pluripotent SCs, Differentiated Cells), Animal) Historic and Forecast Sales By Regions
6.4. Microbial Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL CELL EXPANSION MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Biopharmaceuticals Historic and Forecast Sales By Regions
7.4. Tissue Culture & Engineering Historic and Forecast Sales By Regions
7.5. Vaccine Production Historic and Forecast Sales By Regions
7.6. Drug Development Historic and Forecast Sales By Regions
7.7. Gene Therapy Historic and Forecast Sales By Regions
7.8. Cancer Research Historic and Forecast Sales By Regions
7.9. Stem Cell Research Historic and Forecast Sales By Regions
7.10. Others Historic and Forecast Sales By Regions

8. GLOBAL CELL EXPANSION MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data Analysis By End-use
8.3. Biopharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Research Institutes Historic and Forecast Sales By Regions
8.5. Cell Banks Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL CELL EXPANSION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CELL EXPANSION COMPANIES

10.1. Cell Expansion Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CELL EXPANSION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. GE Healthcare
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Corning Incorporated
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Merck KGaA
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Miltenyi Biotec
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. BD (Becton, Dickinson And Company)
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Upcyte Technologies GmbH
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Terumo BCT Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Sartorius AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Takara Bio Inc.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Trinova Biochem GmbH
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies